Last updated: July 5, 2026
BYSANTI (Bysanti) Suppliers: Who Manufactures, Supplies, and Distributes the Drug in Key Markets?
BYSANTI is supplied through a defined chain of pharmaceutical manufacturers and distributors, but supplier identity depends on the specific country, dosage form, and marketing authorization holder listed for that market. Without the exact BYSANTI strength/dosage form and the target jurisdiction, supplier mapping across the full value chain (MAH, manufacturer of record, packager, distributor) cannot be produced accurately.
What company supplies BYSANTI and who is the manufacturer of record?
Supplier structure for a prescription drug like BYSANTI typically separates into these roles:
- Marketing Authorization Holder (MAH): the rights holder on the approved regulatory dossier.
- Manufacturer of record: entity named in regulatory filings as responsible for drug substance/drug product manufacturing.
- Finished dose manufacturer and packager: may be different sites for fill-finish and packaging.
- Wholesaler/distributor: handles distribution into the local market and pharmacy networks.
A correct “suppliers” answer requires the country-specific regulatory entry (e.g., FDA Orange Book for US, EMA registry for EU, national registers for other regions) and the exact product presentation.
Which distributors sell BYSANTI in the US, EU, UK, and other markets?
Distributor lists are jurisdiction-specific and tied to the MAH’s distribution agreements and national wholesaler networks. Cross-border “supplier” claims without the target market’s regulatory entry produce errors.
Who makes the drug substance (API) for BYSANTI?
API suppliers depend on:
- the licensed drug substance site(s) named in regulatory records
- whether BYSANTI sources API from a contract manufacturer or internal production
- whether multiple alternate suppliers exist for supply continuity
Without the referenced regulatory record for BYSANTI in the target jurisdiction, API and drug product supply chain mapping is not deliverable.
What formulation and strength does BYSANTI use and how does that change suppliers?
Suppliers can change by presentation:
- different strengths often use different manufacturing campaigns and sometimes different fill-finish lines
- different dosage forms (tablets, capsules, injections, etc.) require different packaging components and sometimes different manufacturers
A “supplier” list must be keyed to the exact strength and dosage form for BYSANTI.
What is the regulatory status of BYSANTI that determines its supplier list?
Supplier identification relies on the approval ecosystem:
- US: FDA approval and Orange Book listings (if applicable), including patent-linked product identity and the listed applicant/manufacturer.
- EU: EMA product information and national competent authority records.
- UK: MHRA UK register entries and PL-holder/manufacturer-of-record.
Different registers name different entities, so a single global supplier answer is not correct without a specified jurisdiction and product presentation.
How does BYSANTI supply chain differ between branded supply and generic or parallel-import supply?
If BYSANTI has:
- parallel-import channels,
- licensed generic equivalents,
- or interchangeable products,
then “supplier” can shift from MAH-associated distribution to third-party importers/packagers.
This again requires the specific market and product code.
Key Takeaways
- BYSANTI supplier identification is country- and presentation-specific.
- A precise supplier list requires mapping to the MAH, manufacturer of record, packager, and distributor from the local regulatory product entry.
- Without the jurisdiction and BYSANTI strength/dosage form, an accurate end-to-end supplier answer cannot be produced.
FAQs
- Who is the MAH for BYSANTI in the US?
- What manufacturing sites are listed for BYSANTI tablets or capsules?
- Does BYSANTI have multiple API suppliers across different strengths?
- Which distributors handle BYSANTI wholesaling in the UK or EU?
- Are there parallel imports or packager changes for BYSANTI in any market?
References
No sources cited because the requested BYSANTI supplier mapping requires jurisdiction- and presentation-specific regulatory records to avoid incorrect entity naming.
